The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early-onset stage II/III colorectal adenocarcinoma in the IDEA database: Treatment adherence, toxicities, and outcomes from adjuvant fluoropyrimidine and oxaliplatin.
 
Elisa Fontana
Employment - HCA/Sarah Cannon
Consulting or Advisory Role - Astellas Pharma (I); Bristol-Myers Squibb (I); Celgene (I); SERVIER (I)
Patents, Royalties, Other Intellectual Property - Patent No: 1716712.3 pending (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); SERVIER (I)
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Alberto F. Sobrero
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Amgen; Bayer; Celgene; Menarini; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda
 
Timothy Iveson
Honoraria - SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pierre Fabre; SERVIER
 
Anthony Frank Shields
Consulting or Advisory Role - Caris Life Sciences; ImaginAb
Speakers' Bureau - Caris Life Sciences
Research Funding - Alkermes; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; H3 Biomedicine; Halozyme; Hutchison China Meditech; ImaginAb; Incyte; Inovio Pharmaceuticals; Jiangsu Alphamab Biopharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Plexxikon; Repertoire Immune Medicines; Seagen; Shanghai HaiHe Pharmaceutical; Taiho Pharmaceutical; Telix Pharmaceuticals; Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget
 
Julien Taieb
Consulting or Advisory Role - Amgen; Celgene; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical
Speakers' Bureau - Amgen; Lilly; Merck; MSD; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck; Takeda
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst)
 
Ioannis Souglakos
No Relationships to Disclose
 
Elizabeth Catherine Smyth
Employment - HCA/Sarah Cannon (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Merck; Roche; SERVIER; Zymeworks
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; Roche; SERVIER; Zymeworks
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Merus (Inst); Roche (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; SERVIER
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Infomedica; Lilly; Medscape; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Amgen; Astellas Pharma; Beigene; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; SERVIER; Zymeworks
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pierre Fabre; Roche/Genentech; Sanofi; Servier
Consulting or Advisory Role - Amgen; Bayer; BeiGene; BMS; Lilly; Merck Serono; MSD; Pfizer; Roche; SERVIER; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; ESMO; German Cancer Society; Merck Serono; MSD; Roche
 
Andrea Harkin
No Relationships to Disclose
 
Roberto Labianca
Consulting or Advisory Role - Lilly; Merck Serono; Roche; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Roche; SERVIER
 
Jeffrey A. Meyerhardt
Honoraria - Cota Healthcare; Taiho Pharmaceutical
Research Funding - Boston Biomedical (Inst)
 
Thierry Andre
Honoraria - AMGEN; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Clovis Oncology; GamaMabs Pharma; Gastrointestinal Cancers Advice; HalioDX; MSD Oncology; Pierre Fabre; SERVIER; Tesaro
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; Roche; Roche/Genentech; Ventana Medical Systems
 
Takeharu Yamanaka
Honoraria - Bayer; Chugai Pharma; Takeda
Research Funding - Bayer (Inst); Chugai/Roche (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ioannis Boukovinas
Employment - Pierre Fabre (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; LEO Pharma; Merck; MSD; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genesis Pharma; Ipsen; LEO Pharma; MSD; Novartis; Roche; Sanofi
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Servier
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier; IMEDEX
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche; Lilly (Inst); OBI Pharma
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Irit Ben-Aharon
No Relationships to Disclose
 
Qian Shi
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Merck
Consulting or Advisory Role - Boehringer Ingelheim; Yiviva
Research Funding - Celgene (Inst); Roche/Genentech (Inst)